Amicogen Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amicogen Inc with three other
companies in this sector in South Korea:
sales of 86.07 billion Korean Won [US$72.30 million]
of which 80%
was Health Functional Food Segment),
Hwail Pharmaceutical Company Limited
(102.07 billion Korean Won [US$85.74 million]
Samil Pharmaceutical Co., Ltd.
(94.60 billion Korean Won [US$79.46 million]
Amicogen Inc reported sales of 94.52 billion Korean Won (US$79.40 million)
December of 2018.
increase of 28.3%
versus 2017, when the company's sales were 73.67 billion Korean Won.
Sales at Amicogen Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 308%).